Tag: generic drug safety

Serious Adverse Events: Reporting Procedures for Generic Drugs Explained

Serious Adverse Events: Reporting Procedures for Generic Drugs Explained

Jun, 1 2026

Explore the complexities of reporting serious adverse events for generic drugs. Learn why underreporting occurs, how to identify manufacturers, and the regulatory steps for FDA and EMA compliance.

How FDA Monitors Generic Drug Safety After Approval

How FDA Monitors Generic Drug Safety After Approval

Mar, 31 2026

Discover how the FDA monitors generic drug safety after approval, including key surveillance systems, limitations, and future technological improvements.

Post-Market Surveillance: How the FDA Monitors Generic Drugs After Approval

Post-Market Surveillance: How the FDA Monitors Generic Drugs After Approval

Dec, 15 2025

The FDA monitors generic drugs after approval using real-world data, adverse event reports, and AI tools to ensure ongoing safety. Despite bioequivalence testing, post-market surveillance catches rare side effects and manufacturing issues that clinical trials miss.